| Ytd | -35.55% | |
| 1y | 56.59% |
| Open | 7.12 | Prev Close | 7.02 | Low | 6.82 | High | 7.12 | Mkt Cap | 350.74M |
| Vol | 38.96K | Avg Vol | 153.55K | EPS | -2.50 | P/E | -2.81 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 6.81 | 200-d Avg | 6.53 | 1yr Est | 0.00 |
CV News
SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-sta
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Ado
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH S
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Mon
CapsoVision NASDAQ: CV reported steady first-quarter revenue and said it continues to advance artifi
CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript
SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stag
SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st
CapsoVision (NASDAQ: CV - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are bot
CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript
Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results Reports Prelimina
SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st
CapsoVision (NASDAQ: CV - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report)
CapsoVision, Inc. (NASDAQ: CV - Get Free Report) saw a large increase in short interest in the month
CapsoVision (NASDAQ: CV - Get Free Report) and Profusa (NASDAQ: PFSA - Get Free Report) are both sma
CNBC's Brian Sullivan reports on President Trump's commentary about Venezuela's oil industry during
Shares of CapsoVision, Inc. (NASDAQ: CV - Get Free Report) gapped down prior to trading on Friday. T
CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and str
U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, C
CapsoVision, Inc. (NASDAQ: CV - Get Free Report)'s share price traded down 6.5% on Friday. The stock
CapsoVision's (NASDAQ: CV - Get Free Report) lock-up period will expire on Monday, December 29th. Ca
